Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga January 02, 2015 at 08:38 AM EST Brainstorm Cell Therapeutics Inc.(NASDAQ: BCLI) shares jumped 46.85% to $6.99 in pre-market trading ahead of January 5 conference call ... Read More >> Related Stocks: Brainstorm Cell Regulus Therapeutics